Patent · US Expired

Device and method for the quantitative determination of heparin in mammalian blood plasma

US4543335A · kind A · utility

24Cited by
6References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 1982
Grant dateSep 24, 1985
Priority date
Expiry dateDec 20, 2002

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2400/40
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A device for the quantitative determination of heparin in mammalian blood plasma, a method for the preparation of such device and a method for determining the plasma's heparin concentration using the device. The device, which is prepared using a freeze-drying technique, comprises a first upper layer of a carrier matrix material containing a buffer, AT-III and thrombin and a second, lower layer of a carrier matrix containing a thrombin sensitive fluorogenic or chromogenic substrate being capable of interacting with thrombin in such a manner that a time-related chemical change detectable by fluorometric or spectrophotometric means takes place when thrombin and the substrate are contacted in a suitable liquid environment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.